271 related articles for article (PubMed ID: 29137443)
1. The clinical use of the platelet to lymphocyte ratio and lymphocyte to monocyte ratio as prognostic factors in renal cell carcinoma: a systematic review and meta-analysis.
Wang X; Su S; Guo Y
Oncotarget; 2017 Oct; 8(48):84506-84514. PubMed ID: 29137443
[TBL] [Abstract][Full Text] [Related]
2. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis.
Gu L; Li H; Chen L; Ma X; Li X; Gao Y; Zhang Y; Xie Y; Zhang X
Oncotarget; 2016 May; 7(22):31926-42. PubMed ID: 26942464
[TBL] [Abstract][Full Text] [Related]
4. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis.
Guo J; Fang J; Huang X; Liu Y; Yuan Y; Zhang X; Zou C; Xiao K; Wang J
Int J Surg; 2018 Dec; 60():216-223. PubMed ID: 30468905
[TBL] [Abstract][Full Text] [Related]
6. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer.
Ong HS; Gokavarapu S; Wang LZ; Tian Z; Zhang CP
J Oral Maxillofac Surg; 2017 Aug; 75(8):1762-1774. PubMed ID: 28063763
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis.
Peng H; Luo X
Cancer Cell Int; 2019; 19():70. PubMed ID: 30962764
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysis.
Li W; Tao L; Zhang L; Xiu D
Onco Targets Ther; 2017; 10():3391-3397. PubMed ID: 28744143
[TBL] [Abstract][Full Text] [Related]
9. The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with urological cancers: A meta-analysis.
Li M; Deng Q; Zhang L; He S; Rong J; Zheng F
Pathol Res Pract; 2019 Jan; 215(1):5-11. PubMed ID: 30401580
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis.
Peng LP; Li J; Li XF
World J Clin Cases; 2022 Mar; 10(7):2194-2205. PubMed ID: 35321179
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of Platelet-to-Lymphocyte Ratio in Patients With Bladder Cancer: A Meta-Analysis.
Wang X; Ni X; Tang G
Front Oncol; 2019; 9():757. PubMed ID: 31475109
[No Abstract] [Full Text] [Related]
12. Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: A meta-analysis.
Ma JY; Liu Q
Int J Surg; 2018 Feb; 50():67-71. PubMed ID: 29329786
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of pretreatment platelet to lymphocyte ratio in urologic cancer.
Wang J; Liu Y; Zhang N; Li X; Xin P; Bi J; Kong C
Oncotarget; 2017 Sep; 8(41):70874-70882. PubMed ID: 29050328
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of platelet-to-lymphocyte ratio in urothelial carcinoma patients: a meta-analysis.
Bao Y; Wang Y; Li X; Pan M; Zhang H; Cheng Z; Wang X
Cancer Cell Int; 2019; 19():315. PubMed ID: 31798344
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Hematological Markers for Patients with Nasopharyngeal Carcinoma: A Meta-analysis.
Yang S; Zhao K; Ding X; Jiang H; Lu H
J Cancer; 2019; 10(11):2568-2577. PubMed ID: 31258763
[No Abstract] [Full Text] [Related]
17. Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients.
Lin S; Fang Y; Mo Z; Lin Y; Ji C; Jian Z
World J Surg Oncol; 2020 Jul; 18(1):186. PubMed ID: 32711514
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
[TBL] [Abstract][Full Text] [Related]
19. Prognostic prediction of the platelet-to-lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.
Li DZ; Guo J; Song QK; Hu XJ; Bao XL; Lu J
Transl Cancer Res; 2022 Nov; 11(11):4037-4050. PubMed ID: 36523315
[TBL] [Abstract][Full Text] [Related]
20. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
